Regulatory Strategy Call

A confidential, structured discussion designed to clarify your regulatory position and identify your most practical next steps.

In this session, we typically:

  • Identify gaps in clinical evaluation, performance evaluation, or post-market surveillance strategy,

  • Clarify classification, market scope and approval pathway considerations,

  • Assess audit or Notified Body readiness risks, or

  • Outline the next practical steps

This review is designed for regulatory leaders, founders, and regulatory/clinical teams within medical device and IVD organisations seeking structured, senior-level regulatory input and execution support.

Your session will be led by Alastair Selby, Managing Consultant at SciMed Consultancy Ltd.

There is no need to proceed beyond this discussion

Not ready to schedule a review? >> Submit a Regulatory Enquiry Instead